An enzyme-powered microRNA discriminator for the subtype-specific diagnosis of breast cancer. Issue 8 (31st January 2023)

• Record Type: Journal Article
• Authors: Mao, Huiru; Cao, Ya; Zou, Zihan; Xia, Jianan; Zhao, Jing
• Is Part Of: Chemical science. Volume 14:Issue 8(2023)
• Page Start: 2097
• Page End: 2106
• Publication Date: 2023-01-31
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/d3sc00090g
• Languages: English
• ISSNs: 2041-6520

Abstract

Abstract : This paper reports an enzyme-powered microRNA discriminator to selectively distinguish breast cancer cells from normal cells and further identify subtype-specific features. Abstract : Breast cancer, a disease with highly heterogeneous features, is the most common malignancy diagnosed in people worldwide. Early diagnosis of breast cancer is crucial for improving its cure rate, and accurate classification of the subtype-specific features is essential to precisely treat the disease. An enzyme-powered microRNA (miRNA, RNA = ribonucleic acid) discriminator was developed to selectively distinguish breast cancer cells from normal cells and further identify subtype-specific features. Specifically, miR-21 was used as a universal biomarker to discriminate between breast cancer cells and normal cells, and miR-210 was used to identify triple-negative subtype features. The experimental results demonstrated that the enzyme-powered miRNA discriminator displayed low limits of detection at fM levels for both miR-21 and miR-210. Moreover, the miRNA discriminator enabled the discrimination and quantitative determination of breast cancer cells derived from different subtypes based on their miR-21 levels, and the further identification of the triple-negative subtype in combination with the miR-210 levels. Therefore, it is hoped that this study will provide insight into subtype-specific miRNA profiling, which may have potential use in the clinical management of breast tumours based on their subtype characteristics.